Matches in Wikidata for { <http://www.wikidata.org/entity/Q61924468> ?p ?o ?g. }
Showing items 1 to 52 of
52
with 100 items per page.
- Q61924468 description "assaig clínic" @default.
- Q61924468 description "clinical trial" @default.
- Q61924468 description "clinical trial" @default.
- Q61924468 description "clinical trial" @default.
- Q61924468 description "clinical trial" @default.
- Q61924468 description "ensaio clínico" @default.
- Q61924468 description "ensayo clínico" @default.
- Q61924468 description "ensayu clínicu" @default.
- Q61924468 description "essai clinique" @default.
- Q61924468 description "klinisch onderzoek" @default.
- Q61924468 description "клінічне випробування" @default.
- Q61924468 description "临床试验" @default.
- Q61924468 name "Taribavirin Phase 2 Dose Finding Study for the Treatment of Hepatitis C Virus (HCV)" @default.
- Q61924468 type Item @default.
- Q61924468 label "Taribavirin Phase 2 Dose Finding Study for the Treatment of Hepatitis C Virus (HCV)" @default.
- Q61924468 prefLabel "Taribavirin Phase 2 Dose Finding Study for the Treatment of Hepatitis C Virus (HCV)" @default.
- Q61924468 P1050 Q61924468-AA2E5D10-6CD4-46E6-80DC-E6A4B6C14EAA @default.
- Q61924468 P1050 Q61924468-DC8E5860-F95E-47F6-9753-09A3EF06BCEC @default.
- Q61924468 P1050 Q61924468-FD11F9F3-120C-4FFD-A796-7D1DD0D3C1AF @default.
- Q61924468 P1132 Q61924468-930B957A-89CC-4507-B450-6F7D7617BCE6 @default.
- Q61924468 P1476 Q61924468-CE57AA87-8816-4E1D-9483-4C9858905233 @default.
- Q61924468 P17 Q61924468-6A772982-EAF3-4F27-AAE1-0CA85BB55406 @default.
- Q61924468 P2899 Q61924468-8876FF57-EC48-48D2-A1B1-8F31068853CB @default.
- Q61924468 P3098 Q61924468-B5CD971F-91F6-40F2-8247-1C5E56DFA182 @default.
- Q61924468 P31 Q61924468-36DF8B75-8330-4EB0-93CB-7188E7667E18 @default.
- Q61924468 P4844 Q61924468-63068046-37BB-4346-9E7D-8DBDC63FCAE5 @default.
- Q61924468 P4844 Q61924468-7A75B039-7BE1-468A-91D6-950150A95D43 @default.
- Q61924468 P4844 Q61924468-C5C6A92C-B47B-4339-8559-D05B68CEEF63 @default.
- Q61924468 P580 Q61924468-1B91BB66-5C0E-4B75-A96D-4BEC010A450E @default.
- Q61924468 P582 Q61924468-8242643A-2E6D-4407-AAEE-2B6C83C6237B @default.
- Q61924468 P6099 Q61924468-7CBFFD40-C397-4F65-85E4-BF05B28E7148 @default.
- Q61924468 P8005 Q61924468-3EF305C8-35B8-45E3-89C8-4AE3F1C8E557 @default.
- Q61924468 P8363 Q61924468-08DF6062-3A56-497A-B485-ABDA7BE5DB66 @default.
- Q61924468 P921 Q61924468-F279A8C1-5EB5-4BAD-B92D-CE16DB84DDF7 @default.
- Q61924468 P1050 Q131742 @default.
- Q61924468 P1050 Q154869 @default.
- Q61924468 P1050 Q157661 @default.
- Q61924468 P1132 "+278" @default.
- Q61924468 P1476 "Phase 2 Comparison of Weight-based Doses of Taribavirin Combined With Peginterferon Alfa-2b Versus Ribavirin Combined With Peginterferon Alfa-2b in Therapy-naïve Patients With Chronic Hepatitis C Virus Genotype 1 Infection" @default.
- Q61924468 P17 Q30 @default.
- Q61924468 P2899 "+18" @default.
- Q61924468 P3098 "NCT00446134" @default.
- Q61924468 P31 Q30612 @default.
- Q61924468 P4844 Q20817235 @default.
- Q61924468 P4844 Q421862 @default.
- Q61924468 P4844 Q7160789 @default.
- Q61924468 P580 "2007-03-01T00:00:00Z" @default.
- Q61924468 P582 "2008-04-01T00:00:00Z" @default.
- Q61924468 P6099 Q42824440 @default.
- Q61924468 P8005 Q76651189 @default.
- Q61924468 P8363 Q78089383 @default.
- Q61924468 P921 Q708693 @default.